QIAGEN
The Clinical Study Lead at QIAGEN drives global clinical performance studies for innovative in vitro diagnostic solutions within the Oncology and Biopharma Companion Diagnostics portfolio. This role involves leading study design and strategy, managing regulatory compliance, and collaborating with pharmaceutical partners and clinical sites to ensure high-quality validation. The position is pivotal in supporting the development and regulatory approval of diagnostics that directly impact patient outcomes.
Headquarters
Venlo, Limburg, Netherlands
Company Size
5001-10000 employees
Founded
1984
QIAGEN delivers Sample to Insights solutions that enable customers to unlock insights from the building blocks of life - DNA, RNA and proteins.
Qiagen discloses Bank of America’s 3.05% stake following AFM notification
18 hours ago
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
1 day ago
Jefferies Financial Group Inc. Makes New Investment in Qiagen N.V. $QGEN
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for QIAGEN.
QIAGEN didn’t post a salary, so this is our estimate from similar listings.
12% above the average for this role
Qiagen 'open for discussion' on shareholder value, but CEO stays mum on takeover talk
1 month ago
Global Companion Diagnostics Manager - Hybrid
Caris Life Sciences
Global Study Lead (Molecular Lab)
Roche
Senior Manager, Companion Diagnostics (CDx)
Tempus AI
Senior Manager, Clinical Diagnostics
Regeneron Pharmaceuticals
Senior Clinical Study Manager
Leica Biosystems
Director, Regulatory Affairs Companion Diagnostics
Revolution Medicines